TB-500 Versus Standard Recovery Interventions
TB-500 (2.0mg 2×/week loading) Satellite cell activation, actin polymerisation, VEGF upregulation 30–50% for Grade I–II tears High. 3–4× VEGF increase, sustained angiogenesis Moderate. Supports remodelling phase indirectly Preclinical (rodent models) + observa
This comparison does not assign a generated winner or score.
- TB-500 (2.0mg 2×/week loading)
- Satellite cell activation, actin polymerisation, VEGF upregulation
- 30–50% for Grade I–II tears
- High. 3–4× VEGF increase, sustained angiogenesis
- Moderate. Supports remodelling phase indirectly
- Preclinical (rodent models) + observational case reports
- BPC-157 (250–500mcg daily)
- Growth hormone receptor modulation, fibroblast activation
- 20–40% for soft tissue injuries
- Moderate. Promotes angiogenesis via different pathway
- Low. Primarily early-phase repair
- Preclinical (rodent models)
- Platelet-Rich Plasma (PRP) injection
- Growth factor delivery (PDGF, TGF-β, IGF-1) from concentrated platelets
- 15–30% (highly variable by preparation method)
- Moderate. Transient growth factor spike
- Moderate. Depends on injection timing
- Mixed. Some RCTs show benefit, others show no effect vs placebo
- NSAIDs (ibuprofen, naproxen)
- COX enzyme inhibition, prostaglandin suppression
- None. May delay healing by 10–20%
- Low. Suppresses angiogenesis signalling
- None. May impair collagen synthesis
- Strong evidence for pain relief; emerging evidence suggests delayed healing
- Corticosteroid injection
- Glucocorticoid receptor activation, broad immune suppression
- None. Accelerates pain relief but weakens healed tissue
- Low. Suppresses VEGF and angiogenesis
- Negative. Reduces collagen cross-linking and tensile strength
- Strong evidence for short-term pain control; consistent evidence of long-term tissue weakening
- The bottom line: TB-500's mechanism targets tissue regeneration, not symptom management. NSAIDs and corticosteroids reduce pain quickly but suppress the biological processes required for full structural repair. Creating a tradeoff between immediate comfort and long-term tissue integrity.